...
首页> 外文期刊>The Journal of Urology >Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes.
【24h】

Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes.

机译:开发和评估诺模图以预测阴茎癌和临床阴性淋巴结患者的腹股沟淋巴结转移。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: Optimal management for penile cancer in patients with clinically negative lymph nodes is still under debate. We developed and evaluated a nomogram to stratify patients who are suitable candidates for further treatment. MATERIALS AND METHODS: This study included 110 men with penile cancer and clinically negative lymph nodes from 1990 to 2008. All patients underwent primary tumor resection and regional lymphadenectomy. We retrospectively reviewed medical records and tumor slides. Statistical analysis was done in R with library rms. RESULTS: The lymph node metastasis rate in the entire cohort was 23.6%. The final model, presented as a nomogram, included T stage, grade, lymphovascular invasion and p53 expression. Only lymphovascular invasion showed independent prognostic value on multivariate analysis (p = 0.024). The model also showed good calibration (bootstrap corrected concordance index 0.79). To determine the clinical usefulness of the nomogram we compared it with the European Association of Urology risk classification using decision curve analysis. At a 10% probability threshold our nomogram led to 1 positive result per 100 patients without an increase in the number of false-positive results. At this probability threshold the model also decreased 13 unnecessary interventions per 100 patients without missing more metastatic disease. CONCLUSIONS: We generated a nomogram in patients with clinically node negative penile cancer based on readily available pathological factors. The clinical usefulness of the nomogram was evidenced by decision curve analysis.
机译:目的:临床上淋巴结阴性的阴茎癌的最佳治疗仍在争论中。我们开发并评估了列线图,以对适合进一步治疗的患者进行分层。材料与方法:该研究包括1990年至2008年的110例阴茎癌和临床淋巴结阴性的男性。所有患者均接受了原发肿瘤切除和局部淋巴结清扫术。我们回顾性地回顾了病历和肿瘤切片。在R中使用库rms进行统计分析。结果:整个队列的淋巴结转移率为23.6%。最终的模型以列线图表示,包括T期,分级,淋巴管浸润和p53表达。在多因素分析中,只有淋巴管浸润显示出独立的预后价值(p = 0.024)。该模型还显示出良好的校准(引导校正的一致性指数为0.79)。为了确定列线图的临床实用性,我们使用决策曲线分析将其与欧洲泌尿外科协会风险分类进行了比较。在10%的概率阈值下,我们的列线图导致每100名患者1个阳性结果,而假阳性结果的数量却没有增加。在此概率阈值下,该模型还每100名患者减少了13次不必要的干预,而没有遗漏更多的转移性疾病。结论:我们基于容易获得的病理学因素在临床淋巴结阴性阴茎癌患者中产生了诺模图。决策曲线分析证明了诺模图的临床实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号